CIK: 0001594912
Total reported value
$29.2M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TXG | 10x Genomics Inc-class A | Stock-Other | 96.63% | — | -16.45% | |
| 2 | EPZMEUR | Epizyme INC | Stock-Other | 2.72% | — | +126.96% | |
| 3 | XLRN | Acceleron Pharma INC | Stock-Other | 0.65% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | EPZMEUR | Epizyme INC | +1.3% | +126.96% | Add |
| 2 | TXG | 10x Genomics Inc-class A | +0.8% | -16.45% | Trim |
| 3 | XLRN | Acceleron Pharma INC | -0.1% | — | Unchanged |
| 4 | INSM | Insmed INC | — | EXIT | Sold out |
| 5 | AERIEUR | Aerie Pharmaceuticals INC | — | EXIT | Sold out |
| 6 | RGNX | Regenxbio INC | — | EXIT | Sold out |